These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 27939376)

  • 1. The Promises of Quantitative Proteomics in Precision Medicine.
    Prasad B; Vrana M; Mehrotra A; Johnson K; Bhatt DK
    J Pharm Sci; 2017 Mar; 106(3):738-744. PubMed ID: 27939376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States.
    Sharma S; Suresh Ahire D; Prasad B
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S17-S35. PubMed ID: 33205430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.
    Ahire D; Kruger L; Sharma S; Mettu VS; Basit A; Prasad B
    Pharmacol Rev; 2022 Jul; 74(3):769-796. PubMed ID: 35738681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
    Poulin P; Burczynski FJ; Haddad S
    J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction.
    Galetin A; Zhao P; Huang SM
    J Pharm Sci; 2017 Sep; 106(9):2204-2208. PubMed ID: 28390843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.
    Pan Y; Hsu V; Grimstein M; Zhang L; Arya V; Sinha V; Grillo JA; Zhao P
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S122-31. PubMed ID: 27385170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
    Poulin P
    J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation.
    Ladumor MK; Thakur A; Sharma S; Rachapally A; Mishra S; Bobe P; Rao VK; Pammi P; Kangne H; Levi D; Balhara A; Ghandikota S; Joshi A; Nautiyal V; Prasad B; Singh S
    Sci Rep; 2019 Jul; 9(1):9709. PubMed ID: 31273226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development.
    Heikkinen AT; Lignet F; Cutler P; Parrott N
    Proteomics Clin Appl; 2015 Aug; 9(7-8):732-44. PubMed ID: 25676057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.
    Hartmanshenn C; Scherholz M; Androulakis IP
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):481-504. PubMed ID: 27647273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of drug disposition on the basis of its chemical structure.
    Stepensky D
    Clin Pharmacokinet; 2013 Jun; 52(6):415-31. PubMed ID: 23463353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters.
    Li J; Zhu HJ
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics.
    Bhatt DK; Prasad B
    Clin Pharmacol Ther; 2018 Apr; 103(4):619-630. PubMed ID: 28833066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.
    Al Feteisi H; Achour B; Rostami-Hodjegan A; Barber J
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1357-69. PubMed ID: 26108733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
    Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
    Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model to Predict the Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics Represented by Receptor/Transporter Occupancy of Central Nervous System Drugs.
    Alqahtani S; Kaddoumi A
    Clin Pharmacokinet; 2016 Aug; 55(8):957-69. PubMed ID: 26914771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.